Search Results
Results found for "RAGE Biotech"
- Profiling Immune Cell and Platelet Transcriptomes
utilized a semi-quantitative multiplex PCR method, which allowed for the detection of both abundant and rare
- Propranolol: A “Pick and Roll” Team Player in Benign Tumors and Cancer Therapies
Propranolol, initially prescribed for high blood pressure, irregular heart rate, essential tremor, and
- Targeted Therapies to Reduce Side Effects in Modern Drug Development
December 2021 "Drug development is rarely trivial.
- ⛵Sailing the GPCR Seas: Your Weekly Research Voyage! ⦿ Nov 11 - 17, 2024
superior choice for GPCR calcium signalling GPCR: Structural Insights and Role in Drug Discovery Orion Biotechnology
- Statin-induced increase in actin polymerization modulates GPCR dynamics and compartmentalization
upon modulation of membrane cholesterol and its consequences on membrane dynamics are addressed only rarely
- Harnessing Deep Mutational Scanning for Enhanced Drug Discovery
Trends in Biotechnology , 29 (9), 435–442. https://doi.org/10.1016/j.tibtech.2011.04.003 Fowler, D.
- Synaptic integration of subquantal neurotransmission by co-localized G protein coupled receptors in
fusion at single synapses, relative placement of fusing vesicles and postsynaptic receptors, and the rate effects of 5-HT1B receptor-mediated inhibition are well-fit by simulated modulation of the release rate
- Structural basis of adhesion GPCR GPR110 activation by stalk peptide and G-proteins coupling
The structures also unveil the rarely explored GPCR/G12 and GPCR/G13 engagements.
- Structure-Based Discovery of Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5
to bind to the allosteric site with affinities ranging from 0.43 to 8.6 μM, corresponding to a hit rate
- Successful prednisolone or calcimimetic treatment of acquired hypocalciuric hypercalcemia caused...
Acquired hypocalciuric hypercalcemia (AHH) is a rare disease caused by calcium-sensing receptor (CaSR
- Structure-Based Discovery of Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5
to bind to the allosteric site with affinities ranging from 0.43 to 8.6 μM, corresponding to a hit rate
- Effect Delta-9-tetrahydrocannabinol and cannabidiol on milk proteins and lipid levels in HC11 cells
However, the increasing rate of cannabis use among pregnant women has presented an urgent need to investigate
- How a Failed Experiment Created a Powerful GPCR Imaging Tool
Scientific progress is rarely linear. But depth compounds.
- AlphaFold’s Breakthrough in GPCR Research: Revolutionizing Discovery, Yet Awaiting Experimental Proof
The results were striking: AlphaFold2 outperformed homology models, achieving a 60% hit rate for compounds
- 📰 GPCR Weekly News, May 20 to 26, 2024
receptor 3 Industry News New cannabinoid CB1 receptor antagonists disclosed in Inversago patent Orion Biotechnology
- Crinetics Pharmaceuticals announced the formation of an independently operated new company...
pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare
- 📰 GPCR Weekly News, February 5 to 11, 2024
Clinical Study to Further Evaluate Functional Precision Medicine Platform in Cancer Patients Orion Biotechnology
- 📰 GPCR Weekly News, January 8 to 14, 2024
Learning Model Three GPCR Companies Earn Prestigious Best Places to Work Certification in 2023 Orion Biotechnology
- Misread the Curve, Misjudge the Drug: Rethinking Antagonism in GPCR Pharmacology
The real story lies in the rate at which antagonists bind and unbind .
- Why Intracellular Drugs May Hold the Key to GPCR Therapeutics
This isn’t just theoretical—Kenakin shows data from risperidone, comparing offset rates in open compartments
- 📰 GPCR Weekly News, July 17 to July 23, 2023
Orion Biotechnology Completes Discovery of First-in-Class Molecule Against Undrugged GPCR Target in Four
- 📰 GPCR Weekly News, October 2 to 8, 2023
Submit a logo design by Nov 1st on the Logo Contest page.
- From Farm Fields to GPCR Discovery, GLP-1 and GIP
Growth hormone disorders, while scientifically rich, were relatively rare.
- 📰 GPCR Weekly News, April 24 to 30, 2023
Industry News Orion Biotechnology will be participating in a panel discussion at the LSX World Congress
- Purpose-Driven Opioid Research: Catherine Demery’s Academic Path
s Next in Her Opioid Research Catherine’s current experiments focus on outcomes such as respiratory rate
- 📰 GPCR Weekly News, January 30 to February 5, 2023
in Upcoming Investor and Industry Conferences International Day of Women and Girls in Science Orion Biotechnology
- When the Islet Lit Up: Advancing GPCR Imaging in Native Tissue
The Human Reaction Behind a GPCR Imaging Milestone Scientists rarely talk about the emotional side of
- 📰 GPCR Weekly News - January 9 to 15, 2023
GPCR Jobs Biotechnology and Biological Sciences Doctoral Training Programme Senior QM Manager Director
- 📰 GPCR Weekly News - January 2 to 8, 2023
GPCR Jobs Biotechnology and Biological Sciences Doctoral Training Programme Senior QM Manager Director
- Chemical Drug Matter : Rethinking the Molecules We Choose to Develop In Drug Discovery
Lesson: The structure-response relationship is rarely linear — and observing the unexpected is part









